USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hangzhou Singclean Medical Products Co., Ltd

USPTO PatentsView assignee record - 10 granted patents across 13 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).

10
Total patents granted
13
CPC technology areas
8.8
Avg claims per patent
+800%
5-year filing velocity

The verdict

Hangzhou holds 10 US patents across 13 technology areas, rank #26,472 of 50,000 tracked assignees.

#26,472
of 50,000 US assignees by volume
Top 52%
by Innovation Score (34.6/100)
8.8
avg claims per patent
+800%
filing velocity, last 5 yrs

Portfolio overview

Hangzhou Singclean Medical Products Co., Ltd has been granted 10 US utility patents between 2018 and 2024, placing Hangzhou Singclean Medical Products Co., Ltd at rank #26,472 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.8 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a Foreign Corporation, Hangzhou Singclean Medical Products Co., Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Hangzhou sits between Hamburger's Specialty Vehicles, Inc. (10 patents, rank #26,468) and Harken, Incorporated (10 patents, rank #26,476) - the closest US assignees by grant volume. The composite Innovation Score of 34.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 1 in the 2015–2019 window, a +800% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Hangzhou Singclean Medical Products Co., Ltd's 8.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hangzhou Singclean Medical Products Co., Ltd against peers pursuing similar technology classes.

Who files at Hangzhou's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Hangzhou holds 10 patents at rank #26,472, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Hangzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

35 Top 52% higher than 48% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201820202021202220232024 2
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Hangzhou Singclean Medical Products Co., Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 10.0%
2020 2 20.0%
2021 2 20.0%
2022 2 20.0%
2023 1 10.0%
2024 2 20.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#26,472

Across all tracked assignees

Innovation Score

34.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Hangzhou Singclean Medical Products Co., Ltd hold?
Hangzhou Singclean Medical Products Co., Ltd holds 10 US granted patents filed between 2018 and 2024, spanning 13 technology areas.
What is Hangzhou Singclean Medical Products Co., Ltd's Innovation Score?
Hangzhou Singclean Medical Products Co., Ltd has an Innovation Score of 34.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Hangzhou Singclean Medical Products Co., Ltd focus on?
Hangzhou Singclean Medical Products Co., Ltd's top technology area is A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES) with 7 patents. The company has filed patents in 13 CPC subclasses total.
Is Hangzhou Singclean Medical Products Co., Ltd's patent filing rate increasing or decreasing?
Hangzhou Singclean Medical Products Co., Ltd's recent filing velocity is +800% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Hangzhou Singclean Medical Products Co., Ltd's patents?
Hangzhou Singclean Medical Products Co., Ltd's patents average 8.8 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Hangzhou Singclean Medical Products Co., Ltd patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Hangzhou's 10 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Hangzhou ranks #26,472 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61L - see who else leads that technology area. A61L leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.